In one paragraphArticle in Antimicrobial agents and chemotherapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Marta Hernández-GarcíaServicio de Microbiología, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.ORCID 0000-0003-2857-2572 Blanca Pérez-VisoServicio de Microbiología, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.ORCID 0000-0002-0693-597X Marta Nieto-TorresServicio de Microbiología, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
María García-CastilloServicio de Microbiología, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Malkoa MichelenaServicio de Microbiología, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.
Luis Martínez-MartínezCIBER de Enfermedades Infecciosas (CIBERINFEC), Instituto Salud Carlos III (ISCIII), Madrid, Spain.ORCID 0000-0002-6091-4045 Fernando BaqueroServicio de Microbiología, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.ORCID 0000-0002-7930-3033 Patricia Ruiz-GarbajosaServicio de Microbiología, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.ORCID 0000-0003-4795-0217 Rafael CantónServicio de Microbiología, Hospital Ramón y Cajal and Instituto Ramón y Cajal de Investigación Sanitaria (IRYCIS), Madrid, Spain.ORCID 0000-0003-1675-3173 Funding
CIBERINFEC (CB21/13/00084) CIBERINFEC postdoctoral contractFiBIO-IRYCIS 2021/0442Instituto Salud Carlos III, AES 2022 PI22/01283Instituto Salud Carlos III, AES 2024 PI24/01449Instituto Salud Carlos III, AES 2024 PI24-02026Instituto Salud Carlos III, CIBER CB21/13/00084
6 · The paper itselfAbstract
Ceftazidime-avibactam, meropenem-vaborbactam, and imipenem-relebactam are key therapeutic options for infections caused by KPC-producing
Indexed as
Anti-Bacterial Agentsbeta-LactamasesKlebsiella pneumoniaeAzabicyclo CompoundsBacterial ProteinsBoronic AcidsCeftazidimeDrug CombinationsDrug Resistance, Multiple, BacterialHeterocyclic Compounds, 1-RingHumansImipenemKlebsiella InfectionsMeropenemMicrobial Sensitivity TestsMutationAnti-Bacterial Agentsavibactam, ceftazidime drug combinationAzabicyclo CompoundsBacterial Proteinsbeta-lactamase KPC-3, Klebsiella pneumoniaebeta-LactamasesBoronic AcidsCeftazidimeDrug CombinationsHeterocyclic Compounds, 1-RingImipenemMeropenemmeropenem and vaborbactamNucleosidesrelebactamThienamycinsceftazidime-avibactamcollateral sensitivity to carbapenemsimipenem-relebactamKPC-ST307-K. pneumoniaemeropenem-vaborbactam
Identifiers
PMID42383991
PMCPMC13436382
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390